Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mental Health in Austrian Teenagers (MHAT) (MHAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03301077
Recruitment Status : Completed
First Posted : October 4, 2017
Last Update Posted : March 7, 2019
Sponsor:
Collaborators:
Ludwig Boltzmann Institute Health Promotion Research
Pharmig - Gesundheitsziele aus dem Rahmen-Pharmavertrag
Information provided by (Responsible Party):
Dr. Andreas Karwautz, Medical University of Vienna

Brief Summary:
The purpose of the Mental Health in Austrian Teenagers (MHAT) - Study is to collect the first epidemiological data on mental health and psychiatric disorders in a representative sample of Austrian adolescents between 10 and 18 years.

Condition or disease Intervention/treatment
Mental Disorders Other: 2-phase epidemiological study (screening, interviews)

Detailed Description:

Knowing about the prevalence of psychiatric disorders and related risk and protective factors is essential for the development of prevention programs and therapeutic approaches. Up to now, no epidemiological data on prevalence rates of psychiatric disorders and related risk and protective factors based on a representative sample is available for Austrian adolescents.

The aim of the study is to present rates of behavioral, emotional and social problems as well as prevalence rates of mental disorders. Furthermore the investigators want to examine risk factors, protective factors and quality of life in a large sample of adolescents aged 10 to 18 years. A two step design is chosen for this purpose to obtain diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5):

  1. Phase 1 (screening) is a screening for emotional, behavioral and social problems as well as social and demographic correlates, risk and protective factors and quality of life.
  2. Phase 2 (interviews) includes structured diagnostic interviews to assess psychiatric diagnoses according to DSM-5 criteria with adolescents above a predefined cut-off score in the screening, and a random sample of adolescents scoring below the cut-off.

Layout table for study information
Study Type : Observational
Actual Enrollment : 4000 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: The Mental Health in Austrian Teenagers (MHAT) - Study: First Epidemiological Survey
Study Start Date : January 2013
Actual Primary Completion Date : April 2015
Actual Study Completion Date : April 2015

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
General population
recruited from schools and other institutions like job-centers or child and adolescent psychiatries
Other: 2-phase epidemiological study (screening, interviews)
first phase is the screening phase, second phase is the interview phase




Primary Outcome Measures :
  1. psychiatric problems (diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5) [ Time Frame: 12 months ]
    Screening and interview


Secondary Outcome Measures :
  1. rates of behavioral, emotional and social problems (representation of data collected at interview) [ Time Frame: 12 months ]
    YSR (Youth Self Report) questionnaire

  2. psychiatric disorder related risks and protective factors (representation of data collected at interviews) [ Time Frame: 12 months ]
    Kinder-DIPS (Diagnostisches Interview psychischer Störungen) interview

  3. quality of life (total score, self-perception, parent relation & home life, social support & peers, school environment and bullying) [ Time Frame: 12 months ]
    KIDSCREEN (Kidscreen) questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   10 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
general population
Criteria

Inclusion Criteria:

  • adolescents aged 10-18

Exclusion Criteria:

  • no written informed consent possible due to intelligence or no willingness by parents to include minor

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03301077


Locations
Layout table for location information
Austria
Medical University of Vienna, Dep. of Child and Adolescent Psychiatry
Vienna, Austria, 1090
Sponsors and Collaborators
Medical University of Vienna
Ludwig Boltzmann Institute Health Promotion Research
Pharmig - Gesundheitsziele aus dem Rahmen-Pharmavertrag
Investigators
Layout table for investigator information
Study Director: Andreas Karwautz, MD, Prof Medical University Vienna
Study Director: Wolfgang Dür, Phd, Prof Ludwig Boltzmann Institute LBIHPR

Additional Information:
Layout table for additonal information
Responsible Party: Dr. Andreas Karwautz, Univ. Prof. Dr., Medical University of Vienna
ClinicalTrials.gov Identifier: NCT03301077     History of Changes
Other Study ID Numbers: FA765A0303
First Posted: October 4, 2017    Key Record Dates
Last Update Posted: March 7, 2019
Last Verified: March 2019

Keywords provided by Dr. Andreas Karwautz, Medical University of Vienna:
children and adolescents
mental health
epidemiology
psychiatric disorders

Additional relevant MeSH terms:
Layout table for MeSH terms
Mental Disorders
Psychotic Disorders
Schizophrenia Spectrum and Other Psychotic Disorders